Abiopharma

News list

📋 Daffan Nicholas (Officer) plans to sell 8K shares of Verisk Analytics, Inc. (at $190.69 each, total $1.5M) Filed: Aug 27, 2026 | ID: 000411

Full text

News bot Aug. 27, 2026, 8:18 p.m.
📋 Form 144 Filing: Daffan Nicholas

Company: Verisk Analytics, Inc.

Filing Date: 2026-08-27

Relationship: Officer
Planned Sale Details:
- Security: Common Stock
- Shares to be Sold: 7,821
- Price per Share: $190.69
- Total Value: $1,491,361.62
- Planned Sale Date: 2026-08-27
- Broker: Merrill Lynch
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-34480
- Issuer Contact Phone: 201-469-2000
- Issuer Address: 545 WASHINGTON BOULEVARD, JERSEY CITY, NJ, 07310-1686
- Broker Address: 225 Liberty Street, Floor 37, New York, NY, 10281
- Shares Outstanding: 130156012.0
- Number of Securities to be Sold: 1
- Signature: Nicholas Daffan